Mar. 7, 2013 ? Scientists at UC San Francisco have found a more precise way to turn off genes, a finding that will speed research discoveries and biotech advances and may eventually prove useful in reprogramming cells to regenerate organs and tissues.
The strategy borrows from the molecular toolbox of bacteria, using a protein employed by microbes to fight off viruses, according to the researchers, who describe the technique in the current issue of Cell.
Turning off genes is a major goal of treatments that target cancer and other diseases. In addition, the ability to turn genes off to learn more about how cells work is a key to unlocking the mysteries of biochemical pathways and interactions that drive normal development as well as disease progression.
"We've spent energy and effort to map the human genome, but we don't yet understand how the genetic blueprint leads to a human being, and how we can manipulate the genome to better understand and treat disease," said Wendell Lim, PhD, a senior author of the study. Lim is director of the UCSF Center for Systems and Synthetic Biology, a Howard Hughes Medical Investigator and professor of cellular and molecular pharmacology.
The new technology developed by the team of UCSF and UC Berkeley researchers is called CRISPR interference -- not to be confused with RNA interference, an already popular strategy for turning off protein production.
"CRISPR interference is a simple approach for selectively perturbing gene expression on a genome-wide scale," said Lei Stanley Qi, PhD, a UCSF Systems Biology Fellow who was the lead author of the Cell study. "This technology is an elegant way to search for any short DNA sequence in the genome, and to then control the expression of the gene where that sequence is located."
The technique will allow researchers to more easily and accurately trace patterns of gene activation and biochemical chains of events that take place within cells, Qi said, and will help scientists identify key proteins that normally control these events and that may go awry in disease.
CRISPR Interference vs. RNA Interference
Unlike conventional RNA interference techniques, CRISPR interference allows any number of individual genes to be silenced at the same time, Qi said. In addition, it acts more crisply, if you will, by not turning off untargeted genes the way RNA interference techniques do.
Gene switching by RNA interference was identified more than a decade ago, launching a new research field that has spawned a Nobel Prize and billion-dollar biotech firms. In January, the U.S. Food and Drug Administration announced its first approval of an injectable disease therapy based on a similar interference strategy, a drug to treat a rare form of high cholesterol.
RNA interference blocks the messenger RNA that drives protein protection based on the blueprint contained within a gene's DNA sequence. By preventing protein production, RNA interference may be used to get around the problem of difficult-to-target proteins, a frequent challenge in drug development.
But CRISPR interference acts one step earlier in the cell's protein manufacturing process. "The horse has already left the barn with RNA interference, in the sense that the RNA message already has been transcribed from DNA," said Jonathan Weissman, PhD, a Howard Hughes Medical Investigator and professor of cellular and molecular pharmacology, who is another senior author on the work. "With CRISPR interference, we can prevent the message from being written."
Implications for Regenerative Medicine
CRISPR -- an acronym for "clustered regularly interspaced short palindromic repeats" -- is a system that bacteria use to defend themselves against viruses. CRISPR acts like a vaccine, incorporating bits of genes from viruses. Bacteria can reference this library of virus genes to recognize and attack viral invaders.
Qi and colleagues used a protein from this system, called Cas9, as a chassis into which they can insert any specific RNA partner molecule. The selected RNA serves as an adaptor that determines the target anywhere within the genome. "Targeting the machinery to new sites is extremely flexible and quick," Qi said.
The research team was able to get the system to work in mammalian cells as well as bacterial cells, and is working to improve its efficiency in mammalian cells, including human cells. The team aims to couple the Cas9 chassis to an enzyme that will enable the technology to turn genes on as well as off.
Such a versatile tool could prove valuable in efforts to reprogram cells for regenerative medicine. Lim's own lab is working on reprogramming immune cells to treat cancer.
"The idea is to reprogram cells to do the things we want them to do," Lim said. "We are still unlocking the secrets of the genome to harness the power of cellular reprogramming."
Additional UCSF co-authors of the Feb. 28 Cell study are postdoctoral fellows Matthew Larson, PhD, and Luke Gilbert, PhD. UC Berkeley co-authors are Adam Arkin, PhD, professor of bioengineering; and Jennifer Doudna, PhD, Howard Hughes Medical Investigator and professor of biochemistry. All the study authors are members of QB3, the California Institute for Quantitative Biosciences, which is headquartered at UCSF Mission Bay.
The research was funded by the National Institutes of Health, the Howard Hughes Medical Institute and the National Science Foundation.
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of California - San Francisco. The original article was written by Jeffrey Norris.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Lei?S. Qi, Matthew?H. Larson, Luke?A. Gilbert, Jennifer?A. Doudna, Jonathan?S. Weissman, Adam?P. Arkin, Wendell?A. Lim. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell, 2013; 152 (5): 1173 DOI: 10.1016/j.cell.2013.02.022
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/genes/~3/fWzP4VyhFSU/130307190645.htm
Sylvia Kristel st louis cardinals Steelers Schedule tory burch Al Smith Dinner Herman Melville Books Kyna Treacy
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vPcNBx5ij6PVISPh-ZDGJ6WON8Dgu2W6yy5Ur3HJm6E4TvEd90ByasxJNjUGQiC7eE55_qg3xLMdzZ_SwopGX0FnKVYRbGglY9SZnsYqI=s0-d){kind=small}
Public release date: 5-Mar-2013
Share ] 
Jessica Alba Takes Daughter Shopping in Paris?[The Frisky] Miley Cyrus Working with Little Mix??[HollyWire] Linda Hogan Arrested for DUI?[Right Celebrity] Adele Working on New Bond Song??[The Celebrity Cafe] Emma Stone Tweets in Anagrams?[The Blemish] Rihanna Out and About in Sweats?[The Huffington Post] Selena Gomez Ruined Justin Bieber’s Birthday??[Celeb Dirty Laundry] Drake Shares His Wealth in ...
?This is the original concept shot for Fruit Ninja which was pitched to the company during Halfbrick Fridays. This is literally the very first piece of Fruit Ninja imagery ever created, so it?s historically significant,” Halfbrick Studio‘s Chief Marketing Officer Phil Larsen said in an email to me last week after I interviewed him and his colleague Richard McKinney, the company’s Chief Technology Officer, about how the company develops its games. Halfbrick Fridays is one of the ways the Brisbane, Australia-based company comes up with new ideas for its games. Fruit Ninja – its greatest hit to date – came out of this. Halfbrick Fridays About five to seven times a year, the company organizes these Halfbrick Fridays, they told me, where the whole company (about 70 people at this point), breaks into groups of around five people to brainstorm new ideas. The cool thing here is that it’s not just the game designers and developers who participate, but anybody who works for the company – be that in accounting or quality assurance – participates in these sessions. Age of Zombies, for example, is the result of this process (though Larsen and McKinney told me the final version looked very different from the prototype). So is Monster Dash. These events either last for about a week or are spread out to one day during a period of about five to seven weeks. Once the idea for Fruit Ninja was born, it only took a few months to make, but some game ideas, the team told me, have been floating around for years and have yet to become reality. From Idea To Game What’s interesting about how Halfbrick turns its game ideas into actual products is that virtually all of its games use one underlying engine (written almost exclusively in C++). The core engine team consists of six “hardcore programmers,” as McKinney told me, and they ensure that those teams that work on the individual games have a stable architecture that they can then write their own code for. One of Halfbrick’s larger teams, by the way, is now the cloud service team that provides the back-end technology to connect games together across platforms. Halfbrick uses Amazon’s EC2 platform for this and recently switched to a NoSQL database for better scalability. The point of the core engine, the team stressed, is to be able to publish apps across platforms as easily